RISANKIZUMAB-RZAA

1 FDA products 1 manufacturers SUBCUTANEOUS

RISANKIZUMAB-RZAA is an active ingredient listed in 1 FDA drug label records from 1 manufacturers taken by subcutaneous route marketed mainly as human prescription drug products.

About RISANKIZUMAB-RZAA

RISANKIZUMAB-RZAA appears as the active ingredient in 1 FDA drug label records. These products are produced by 1 distinct manufacturers, with the largest catalogues from AbbVie Inc.. In this ingredient’s product set, the most common route of administration is subcutaneous. Approved labelling for these products most frequently references: pediatric patients, years age, moderately severely, skyrizi indicated, plaque psoriasis, psoriatic arthritis, crohn disease, ulcerative colitis. Every record below is taken from FDA Structured Product Labelling data; use it to compare brand names, strengths and manufacturers before speaking with a pharmacist.

How it is supplied

Dosage formProductsRouteProducts
— — SUBCUTANEOUS 1
— — — —
— — — —
— — — —
— — — —
— — — —

Main manufacturers

ManufacturerProductsMarketing type
AbbVie Inc. 1 HUMAN PRESCRIPTION DRUG

FDA drug products containing RISANKIZUMAB-RZAA

Brand nameManufacturerTypeRouteDosage form
Skyrizi AbbVie Inc. HUMAN PRESCRIPTION DRUG SUBCUTANEOUS

Frequently asked questions

How many FDA drug products contain RISANKIZUMAB-RZAA?
1 FDA drug label records list RISANKIZUMAB-RZAA as the active ingredient, supplied by 1 manufacturers. The table below lists the brand names, manufacturers and dosage forms covered by those labels.

Which companies make RISANKIZUMAB-RZAA products?
The manufacturers with the most RISANKIZUMAB-RZAA label records are AbbVie Inc.. Generic and brand versions may be produced by different companies.

Is this a substitute for medical advice?
No. This page reproduces FDA labelling data so you can identify a product and its manufacturer. Dosing, interactions and suitability must be confirmed with a prescriber or pharmacist.

This page reproduces FDA Structured Product Labelling data for identification purposes. It is not medical advice and does not recommend, sell or price any medicine.